International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
An Innovative Approach towards Construction, Evaluation, Simulations and Cloning of a Multi-epitope Vaccine against Ebola Virus, through Immunoinformatics-based Study Design
| Author(s) | Dr. Paushali Pal |
|---|---|
| Country | India |
| Abstract | Introduction Ebola virus has been preying on human populations for a long time. But recent outbreaks in Africa with symptoms such as severe haemorrhagic fever urge the immediate need for research on an Ebola vaccine as an initial step. Hence, in this study, an in silico vaccine is designed against the Ebola virus, with epitopes representing all three strains: Zaire, Sudan, and Bundibugyo. Methodologies After initial sequence retrieval, they are prioritized based on physicochemical analyses and other suitable parameters. Epitopes are then predicted from selected sequences and subjected to stringent analyses – antigenicity, allergenicity, toxicity, conservation, solubility, among other parameters. An in silico vaccine is constructed using epitopes, incorporating Beta-defensin 3 at the C-terminus and a His6 Tag at the N-terminus. After a stringent set of analyses, the protein structure is subjected to Secondary and Tertiary structure prediction. After refinement of the structure, validation procedures are performed using PROCHECK, PRO-SA, and Molprobity. Simulation methods such as GROMACS and Immune Simulations, as implemented in C-IMMISIM, are used. Thereafter, docking with TLR4 (in PATCHDOCK software) , interaction analyses of the docking mechanism , by PISA software, Codon Optimization by JCAT and cloning into the pET28a(+) with SnapGene , are achieved. Results After applying stringent analytical methods, epitopes are selected for in silico vaccine construction against Ebola virus strains – Zaire, Sudan, and Bundibugyo. The constructed vaccine is subjected to similar analyses again, yielding a Vaxijen score of 0.6853. Secondary structure prediction by PSIPRED ensures reliable conformity, while tertiary structure prediction by Colab AlphaFold2 further reveals the vaccine structure. After refinement, the validation process reveals that the protein vaccine structure contains over 98% Ramachandran-favoured regions and an ERRAT score of 71%. Docking of the vaccine against the TLR4 immune receptor by PATCHDOCK is achieved, and PISA interaction analyses reveal a binding energy of -14.5kcal/mol. Again, Molecular Dynamics simulations reveal its structural integrity and conformity amid solvation analyses. Then, for C-IMMISIM results, both humoral and cell-mediated immunity are activated, along with memory cell propagation. Again, in JCAT, the CAI score is 0.9572, and a GC content of 52.95% is achieved, indicating high expression potential. Conclusion The immunoinformatics tools applied suggest its conformational integrity, compactness, and safety for further wet-lab research. World -class population coverage of 87.44% , along with approx 70% coverge for West, East and Central Africa , reflects the need for further labotory-based experiments with this vaccine candidate. |
| Keywords | Immunoinformatics, Vaccine design, Codon optimisation, In silico cloning, Molecular dynamics simulation, Epitope prediction. |
| Field | Biology |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-07-21 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i04.84200 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals